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2Summary
Nonribosomal peptide synthetase (NRPS)-like enzymes catalyse the non-oxidative
homodimerisation of aromatic α-keto acids, but the exact reaction mechanism is unknown. The
furanone-forming thioesterase domain of the Aspergillus terreus aspulvinone E synthetase
MelA displays a predicted quinone-forming motif, whereby its catalytic triad contains an
essential cysteine indicating an unusual thioester intermediate. To convert MelA into a
quinone-forming atromentin synthetase its thioesterase domain was replaced with that from a
Paxillus involutus or A. terreus atromentin synthetase. Phylogenetic proximity of donor and
acceptor seems important as only replacement with the A. terreus thioesterase was functional.
Heterologous expression of atromentin synthetases in Aspergillus niger and Aspergillus oryzae
revealed host-dependent product formation whereby cross-chemistry directed atromentin
biosynthesis in A. niger towards atrofuranic acid. Screening of aspergilli from section Nigri
identified an atromentin synthetase in Aspergillus brasiliensis that produced atrofuranic acid
in the homologous host. Therefore, cross-chemistry on quinone cores appears common to
section Nigri.
3Introduction
Non-ribosomal peptide synthetase (NRPS)-like enzymes are widespread in the fungal
kingdom, and even closely related species seem to contain a large number of non-homologous
enzymes. For instance, Aspergillus terreus contains 15 NRPS-like genes (van Dijk, Guo and
Wang, 2016) and 14 NRPS-like genes are found in Aspergillus nidulans (Yeh et al., 2012).
Corresponding to other NRPSs, NRPS-like enzymes are composed of several catalytic
domains. They feature an adenylation (A), thiolation (T) and thioesterase (TE) or, alternatively,
a reductase (R) domain, but lack the condensation domain (C) of prototypical NRPSs (van
Dijk, Guo and Wang, 2016). Therefore, rather than forming peptide bonds from individual
amino acids, NRPS-like enzymes generally catalyse the condensation of two identical α-keto 
acids. For a long time, the importance of NRPS-like enzymes in the production of secondary
metabolites had been neglected and biochemical information on their catalytic properties were
rare (Schneider et al., 2007). However, in recent years it has been shown that NRPS-like
enzymes, either alone or embedded in gene clusters, produce metabolites important for fungal
development and environmental competition. The first fungal product confirmed to derive from
a gene cluster containing an NRPS-like enzyme was terrequinone A (1) (for metabolite
structures refer to Fig. 1) from Aspergillus nidulans (Bok et al., 2006; Balibar, Howard-Jones
and Walsh, 2007). While the direct contribution of terrequinone A to environmental
competition has not been described yet, terrequinone A exhibits cytotoxic activity (He et al.,
2004). The -butyrolactones from A. terreus are also formed by NRPS-like enzymes (Guo et
al., 2013) and have been shown to stimulate sporulation in submerged cultures and increase
the production of secondary metabolites such as lovastatin (Schimmel et al., 1998). In addition,
butyrolactone I (2) can scavenge reactive oxygen species and acts as inhibitor of α-glucosidase, 
which is an important feature for the treatment of type 2 diabetes (Dewi et al., 2012).
Aspulvinone E (3) is the precursor of the Asp-melanin pigment in A. terreus conidia that is
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(Geib et al., 2016). Another NRPS-like enzyme from A. terreus was shown to direct the
biosynthesis of phenguignardic acid (4) (Sun et al., 2016), which had previously been reported
from the grape black rot fungus, Guignardia bidwelii, together with the structurally related
guignardic acid (5) (Molitor et al., 2012; Rodrigues-Heerklotz et al., 2001). These two
dioxolanone natural products were demonstrated to cause plant leaf necrosis and might thus
act as virulence factors of G. bidwelii (Molitor et al., 2012). Furthermore, the ectomycorrhizae-
forming basidiomycete Paxillus involutus produces atromentin (6) that is subsequently
converted into involutin (Braesel et al., 2015) and is assumed to contribute to the oxidative
degradation of lignocellulose via Fenton chemistry by reducing Fe3+ to Fe2+ (Shah et al., 2015).
Atromentin also possesses estrogenic activity and may act as potent inhibitor of 17-β-
hydroxysteroid dehydrogenase (Dellafiora et al., 2019). Very recently, an atromentin
synthetase has also been identified from A. terreus by recombinant expression of the atrAAt
gene in yeast, but the naturally inducing conditions in A. terreus have not been identified yet
(Hühner et al., 2018). These and other examples show that NRPS-like enzymes are widespread
in the fungal kingdom. They direct fungal development and support virulence and nutrition.
Furthermore, due to described antitumor and antidiabetic properties, this class of compounds
has several interesting pharmaceutical characteristics.
The α-keto acids of the aromatic amino acids phenylalanine, tyrosine and tryptophan provide 
the major substrates of fungal NRPS-like enzymes (Hühner et al., 2018). This is at least true
for all examples mentioned above except for guignardic acid (5) for which the molecular basis
of its biosynthesis is still unknown. The condensation of aromatic α-keto acids results in a 
variety of interconnecting core ring structures, which in non-reducing NRPS-like enzymes was
proposed to be performed by the thioesterase domain of these enzymes (Balibar et al., 2007;
Braesel et al., 2015). While the exact mechanism of product formation by the thioesterase
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specify the formation of the core ring structures. A motif with a catalytic triad made from
serine, asparagine and histidine in combination with a branched-chain aliphatic amino acid and
two proline residues was described to be consistent with the formation of a core quinone ring
structure as found in atromentin (6). In contrast, furanone structures were assumed to be formed
by a triad made from serine, aspartate and histidine (Braesel et al., 2015) as found in
microperfuranone (7) biosynthesis by MicA from A. nidulans (Yeh et al., 2012) or ralfuranone
B (8) biosynthesis by RalA from the bacterium Ralstonia solanacearum (Wackler et al., 2011).
On the contrary to this prediction, the NRPS-like proteins MelA and ApvA from A. terreus
form a furanone in aspulvinone E (3) and aspulvinone H (9) but show a sequence motif similar
to that of quinone forming TE-domains except that the serine residue in the catalytic triad is
replaced by a cysteine (Geib et al., 2016). As the InvA atromentin synthetases from P. involutus
and the aspulvinone E synthetase from A. terreus both use the substrate p-
hydroxyphenylpyruvate, our intention was to perform mutation analyses on the melA gene to
identify the contribution of specific amino acids in product formation. Accordingly, by using
expression systems that base on the transcriptional activator TerR from terrein biosynthesis in
combination with its terA target promoter (Gressler et al., 2015; Geib and Brock, 2017) we
expressed different versions of the melA and the invA5 gene and characterised the
corresponding products. Additionally, we studied the products formed from the A. terreus
atromentin synthetase AtrAAt in different expression platform strains (Hühner et al., 2018) and
determined the products of a yet uncharacterised NRPS-like enzyme from Aspergillus
brasiliensis with similarity to aspulvinone E and atromentin synthetases.
Results
6Mutation of C733S and N760D in the aspulvinone E synthetase MelA from Aspergillus
terreus
A sequence alignment of thioesterase domains of the aspulvinone E and H synthetases MelA
and ApvA from A. terreus revealed sequence motifs matching with the predicted sequence
motif of quinone core formation as found in the atromentin synthetase InvA5 from P. involutus
rather than the predicted furanone motif as found in the microperfuranone synthetase MicA
(Fig. 2A). However, MelA and ApvA that were identified as furanone synthetases both possess
a cysteine instead of a serine in the postulated catalytic triad. This suggests that during furanone
core structure formation in aspulvinone E (3) biosynthesis the intermediate is bound via a
thioester rather than an oxoester. As MelA activity was found to depend on a reducing
environment (Geib et al., 2016), the thiol group was assumed to be essential. To confirm this
assumption and to test whether a change of the catalytic triad from a cysteine into a serine alters
product formation, a C733S mutation was introduced. The mutated gene was cloned with an
N-terminal His-tag into the SM-Xpress vector (Gressler et al., 2015) and used for
transformation of the A. niger expression platform strain P2. No change in the metabolite
profile compared to the parental strain was observed with the C733S mutant, although enzyme
purification confirmed the production of a full-length protein (Fig. 2B). In addition, an in vitro
assay with native and mutated MelA only revealed product formation with the wild type, but
not with the C733S mutant (Fig. 2C). This indicates that the cysteine in the thioesterase domain
is essential in the formation of aspulvinone E (3). We next analysed the importance of
asparagine 760 in MelA, which also matches the pattern in quinone, but not furanone core
forming enzymes (Fig. 2A). Like the C733S mutant, a N760D mutant was generated and
expressed in A. niger. Again, no metabolite was produced and also the purified enzyme (Fig.
2B) did not show product formation (Fig. 2C). These results indicate that both amino acids,
C733 and N760 essentially contribute to the catalytic mechanism and/or the correct folding of
7the thioesterase domain of the aspulvinone E synthetase, but the core motifs predicted to
discriminate between quinone and furanone core formation seem to be more complex.
Generation of a chimeric MelA(A):InvA5(T-TE) protein
As the mutation of C733 and N760 in MelA inactivated the enzyme, we were interested,
whether replacement of the MelA thiolation and thioesterase domains with those from P.
involutus InvA5 convert the aspulvinone E synthetase into an atromentin synthetase. Previous
studies on the aspulvinone H synthetase ApvA from A. terreus showed that an exchange of the
thiolation and thioesterase domain with that from the butyrolactone IIa (10) synthetase BtyA
from A. terreus successfully converted the enzyme into a butyrolactone synthetase (van Dijk,
Guo and Wang, 2016). To produce a chimeric MelA:InvA5 protein highly conserved residues
in the stretch between adenylation and thiolation domain were selected for generating the
MelA(A):InvA5(T-TE) fusion protein. While a full-length protein was successfully re-isolated
from A. niger (Fig. 2B), neither under in vivo nor under in vitro conditions (Fig. 2C) atromentin
(6) or any other metabolite was detected. This observation led to the following hypotheses: (i)
as InvA5 derived from a basidiomycete, it might not properly fold when produced in the
ascomycete A. niger; (ii) the reaction mechanism discriminating furanone and quinone core
formation is also directed by the A domain or (iii) the gene fusion was placed at an incompatible
position.
Heterologous expression of the atromentin synthetase invA5 in A. niger
To test the first hypothesis that InvA5 cannot be produced as a functional protein in A. niger,
we cloned the full-length invA5 gene including an N-terminal His-tag into the SM-Xpress
expression vector and transformed several A. niger expression platform strains. These included
the sugar inducible P2 strain (Gressler et al., 2015) and the doxycycline inducible ATNT16
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Furthermore, the sugar inducible expression system was transferred into A. niger N402 and the
resulting expression platform strain NP4 was also used for invA5 expression. Transformants
produced a bright yellow culture broth under inducing conditions, which was extracted for
metabolite analysis. While a single major metabolite peak for atromentin (6) was expected,
only a very minor peak identical with the retention time and UV/VIS profile of atromentin was
observed (Fig. 3A and Fig. S1). By contrast, several other major metabolite peaks (11, 12, 13,
X) were detected with strikingly different retention times compared to atromentin (6).
However, when InvA5 was purified and subjected to an in vitro assay, atromentin (6) was the
exclusive metabolite produced from the substrate p-hydroxyphenylpyruvate (Fig. 3D).
Furthermore, when a crude cell-free extract of an invA5 expressing A. niger strain was used in
an enzymatic assay with 4-hydroxyphenylpyruvate as substrate, traces of 13 were detected as
a carry-over from the cell-free extract and atromentin (6) was the major metabolite produced
(Fig. S1C). This confirms that InvA5 is functionally produced in A. niger, but under in vivo
conditions atromentin biosynthesis seems to undergo unexpected modifications that are not
observed in cell-free extracts.
Time-dependent metabolite production from invA5 expression in A. niger
While InvA5 was confirmed to act as atromentin synthetase under in vitro conditions, several
different metabolites were produced in the heterologous host A. niger regardless the expression
platform strain used. However, peak intensities of individual metabolites strongly varied
among the different strains in this screening. Therefore, we selected individual transformants
and extracted culture supernatant and mycelium at different time points (Fig. 3A-B and Fig.
S1). A metabolite at a retention time of 14.99 min (13) and with a molecular mass of 340.29
g/mol was dominant at early time points, but its intensity in the culture broth decreased during
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supernatant. In agreement, this metabolite was nearly exclusively isolated from the mycelium
at 36 and 48 h. Furthermore, at least three other dominant metabolites with molecular masses
of 342.30 g/mol (X), 312.28 g/mol (11) and 138.12 g/mol (12) (retention times 3.74 min, 4.88
min and 5.09 min) accumulated during cultivation.
Identification of metabolites from heterologous invA5 expression in A. niger
Metabolite X showed an exact molecular mass of 341.0669 [M-H]- resulting in a sum formula
of C18H14O7. Stability issues prevented the structural elucidation of this compound. In contrast,
structures of metabolites with exact masses of m/z 339.0514 [M-H]- (13) and m/z 311.0566 [M-
H]- (11) as well as that of metabolite (12) with an exact mass of m/z 137.0232 [M-H]- were
elucidated by NMR spectroscopy. Metabolite (11) was identified as gyroporin, a known
atromentin-derived metabolite in P. involutus (Besl et al., 1973). Metabolite (12) was identified
as p-hydroxybenzoic acid (table S1).
The molecular formula of the previously undescribed atrofuranic acid (13) was determined as
C18H12O7 by high resolution ESI-MS measurement (m/z 340.0583), which is consistent with
13 degrees of unsaturation. The 1H NMR spectrum showed only four signals in the aromatic
range. These signals were ascribed to two p-substituted benzene residues based on their
chemical shifts, splitting, and 2D NMR correlations (Fig. S2-S4 and tables S2). The deduced
number of eight aromatic protons together with the molecular formula indicated that 13 must
contain four hydroxyl groups with exchangeable protons. Because the treatment of 13 with
acetic anhydride in pyridine yielded exclusively a triacetylated product (14) (Fig. S2-S4 and
table S3), it became evident that one hydroxyl group in 13 is part of a carboxylic acid moiety
(Chattaway, 1931). The remaining two oxygen atoms are due to a ketone, which shows a
resonance at 180.6 ppm in the 13C NMR spectrum, and an ether function, respectively. The
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four, yet unassigned signals in the 13C NMR spectrum possess chemical shifts characteristic of
sp2-hybridized carbons and were thus attributed to two carbon-carbon double bonds. The
presence of two benzene rings, two carbonyl groups and two C-C double bonds in 13 left a
single degree of unsaturation unassigned, which must be due to another ring structure.
Consolidating the above information with the chemical shifts of the respective nuclei as well
as data from a heteronuclear multiple bond correlation (HMBC) experiment, the structure of
13 was finally elucidated. As evidenced by the signal doubling in the 13C NMR spectrum, 13
is subject to keto-enol tautomerism and, therefore, exists as a mixture of E and Z isomers. After
feeding A. niger cultures with 2-13C-labelled tyrosine, spectroscopic analysis of isolated 13
revealed four intensified 13C NMR signals (Fig. S3) that were in agreement with the proposed
structure of atrofuranic acid and its tautomerism.
Metabolite production from atrofuranic acid
To elucidate the interconnection of products formed by heterologous expression of the
atromentin synthetase InvA5 in A. niger, feeding studies were performed. When atromentin (6)
was fed to A. niger cultures, subsequent product analysis did not provide any evidence for the
presence of atrofuranic acid (13), metabolite X (X), gyroporin (11) or p-hydroxybenzoic acid
(12). This indicates that either externally added atromentin (6) does not enter A. niger or that
atromentin (6) does not act as precursor for any of these metabolites. Therefore, atrofuranic
acid (13) was added to A. niger ATNT16 cultures and to a control medium (Fig. 3C). Analysis
of the control revealed the presence of p-hydroxybenzoic acid (12), indicating that 13 can
spontaneously decompose into 12 in the culture broth. However, when A. niger cultures
supplemented with 13 were extracted, 12 was detected along with metabolite X (X) and
gyroporin (11). This implies that atrofuranic acid (13) is the prime metabolite formed by
heterologous expression of the invA5 gene in A. niger with all other metabolites deriving from
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this compound. Furthermore, metabolite X and gyroporin (11) production seems dependent on
the presence of A. niger cells.
Heterologous invA5 and melA expression in A. oryzae
Our data showed that InvA5 was produced as a functional protein in A. niger, whereby under
in vivo conditions a cross-chemistry during product formation resulted in the production of a
furanic acid core structure. To investigate whether atromentin (6) production is generally
directed towards other metabolites in Aspergillus species, we introduced the A. terreus
transcriptional regulator gene terR under control of the PamyB promoter (Gressler et al., 2015)
into the genome of Aspergillus oryzae RIB40. The single copy transformant OP12 was selected
as A. oryzae expression platform strain. Cultivation of OP12 and its parental RIB40 strain in
glucose or starch containing minimal medium revealed no significant background production
of secondary metabolites in either strain (Fig.4A).
To test the general suitability of OP12 to produce metabolites from an NRPS-like enzyme, we
first introduced the A. terreus melA gene under control of the terA promoter. As with melA
expression in the A. niger P2 strain (Geib et al., 2016), production of aspulvinone E (3) and its
UV-interconvertible isomer isoaspulvinone E (#) was confirmed by HPLC analysis from
culture extracts of the OP12 melA strain (Fig. 4A). Next, we transformed the OP12 strain with
the invA5 expression construct. Transformants secreted a purple metabolite into the solid and
liquid growth medium. Analytical HPLC from culture extracts revealed a single metabolite
peak matching the retention time and UV spectrum of authentic atromentin (6) (Fig.4B). This
experiment confirmed that cross-chemistry on the benzoquinone core of atromentin (6) does
not occur in A. oryzae and no other metabolites were detected in this expression host. This
indicates further that the physiology of Aspergillus species used for heterologous gene
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expression differs and is important for identification of metabolites from a specific yet
uncharacterised gene of interest.
Generation of chimeric proteins by domain fusions from MelA and AtrAAt
Analyses showed that InvA5 is functionally expressed in A. niger and A. oryzae, which
indicates that the failure to retrieve a functional chimeric protein from the fusion of MelA with
InvA5 was either due to selection of an incorrect protein fusion site or an incompatibility
between an A. terreus (ascomycete) and P. involutus (basidiomycete) enzyme. To test these
assumptions further, we fused the MelA protein with the atromentin synthetase AtrAAt from A.
terreus (Hühner et al., 2018) and selected two different fusion sites. The first construct (C1)
used the identical fusion site as selected for the fusion of MelA and InvA5 resulting in
MelA(A):AtrAAt(T-TE). In the second construct (C2) we only replaced the thioesterase domain of
MelA resulting in the chimeric protein MelA(A-T):AtrAAt(TE). Both gene fusions as well as the
full-length atrAAt gene were cloned into the tag-SM-Xpress expression plasmid (Geib et al.,
2016) for transformation of the A. oryzae OP12 and A. niger ATNT16 expression platform
strains. A. oryzae transformants secreted a purple metabolite and HPLC analyses of extracts
confirmed the production of atromentin (6) from all three constructs (Fig. 4C). In contrast, all
A. niger transformants regardless of the integrated construct produced a yellow culture broth
and mycelium under inducing conditions. In agreement, HPLC analyses of mycelium
extractions confirmed the production of atrofuranic acid (13) (Fig. 4D). As functional proteins
were produced from both gene fusion strategies, the fusion site selected for generation of the
MelA(A):InvA5(T-TE) chimeric protein was suitable and unlikely to cause the production of an
inactive enzyme. More importantly, this experiment indicated that the thioesterase domain
directs the chemistry of an NRPS-like enzyme and a furanone-forming enzyme can be
successfully converted into a quinone-forming enzyme by exchange of the TE-domain. To
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confirm this assumption, we also produced a fusion protein that contained the A- and T-domain
of the atromentin synthetase AtrAAt and the TE-domain of MelA. The gene fusion was cloned
into the tag-SM-Xpress vector and used for transformation of the A. oryzae OP12 and A. niger
ATNT16 expression platform strains. Culture supernatants turned into a fluorescent yellow
indicating the production of aspulvinone E (3) and its UV-interconvertible isomer
isoaspulvinone E (#) (Geib et al., 2016), which was confirmed by HPLC analysis of culture
extracts (Fig. 4C and D; construct atrAAt:melA C2). Therefore, we conclude that a successful
replacement of the thioesterase domain of an NRPS-like enzyme depends on the phylogenetic
relationship of the fusion partners. Furthermore, while the furanone core containing product
aspulvinone E (3) is produced in both, A. niger and A. oryzae, the product formed from
atromentin synthetases differs among the two species. While A. oryzae produces atromentin
(6), the major primary metabolite produced in A. niger is atrofuranic acid (13).
Identification of an atromentin synthetase from Aspergillus brasiliensis
As A. niger mainly produced atrofuranic acid (13) from the expression of atromentin synthetase
genes, we were interested in metabolites produced from NRPS-like enzymes in aspergilli from
section Nigri. For this purpose, we used the MelA protein sequence from A. terreus as a
template and screened the genome of Aspergillus brasiliensis strain CBS101740. A protein
with accession number OJJ76880 was identified that when used as a template in BLAST
searches against A. terreus revealed the best hits with the atromentin synthetase AtrAAt (57%
identity, 72% similarity; accession AUO29225), the aspulvinone H synthetase ApvA (54%
identity, 72% similarity, accession AUO29222) and the aspulvinone E synthetase MelA (55%
identity, 72% similarity; accession AND66115). This shows that a simple BLAST analysis of
NRPS-like enzymes does not necessarily allow the prediction of the metabolite produced.
However, it appeared likely that the A. brasiliensis enzyme, subsequently called AbrA,
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produces an atromentin-like metabolite, as no cysteine was detected in the active site of the
thioesterase domain. To confirm this assumption, the abrA gene was amplified from genomic
DNA of A. brasiliensis CBS101740 and cloned into the tag-SM-Xpress expression vector and
used for transformation of A. niger ATNT16 and A. oryzae OP12. In A. niger, the culture
supernatant and mycelium turned into bright yellow, whereas A. oryzae produced a purple
compound (Figure 4E), indicating that the A. brasiliensis abrA gene encodes an atromentin
synthetase. When extracts were analysed by HPLC, this assumption was confirmed as
metabolite X, gyroporin (11), p-hydroxybenzoic acid (12) and atrofuranic acid (13) were
identified from A. niger extracts, whereas a single metabolite peak of atromentin (6) was
detected from the OP12 strain. Furthermore, atromentin (6) was the sole product produced
under in vitro conditions from purified AbrA (Fig. S1D). This shows that atromentin
synthetases are common to ascomycetes and more specifically shows that A. brasiliensis
belonging to the section Nigri possesses such an enzyme.
Cross-chemistry on benzoquinones in section Nigri
Preliminary trials to identify atromentin from A. brasiliensis under some selected cultivation
conditions failed (Fig. S5). We were, therefore, interested in the fate of atromentin (6)
biosynthesis when induced in A. brasiliensis. Therefore, the atromentin synthetase gene abrA
was cloned under control of the constitutively expressed Aspergillus nidulans gpdA promoter
and A. brasiliensis was transformed using pyrithiamine as selection marker. Positive
transformants were cultivated in glucose containing minimal medium and the culture broth and
mycelium were extracted and analysed for the metabolite profile. The parental A. brasiliensis
wild-type strain served as negative control. Unexpectedly, no atromentin (6) was identified
from transformants, whereas peaks with retention times and UV/Vis spectra of atrofuranic acid
(13) and p-hydroxybenzoic acid (12) were detected (Figure 4F). Further inspection of the
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genomic region surrounding the abrA gene identified a putative biosynthesis gene cluster
including a predicted hydroxylase, an oxidoreductase, an O-methyltransferase, a
monooxygenase, a CYP450 protein, and an MFS transporter (Figure 4G). This leads to the
speculation that if atromentin is produced under certain growth conditions, it might get
instantly converted into a yet unknown metabolite. However, it appears even more likely that
atrofuranic acid (13) is the precursor molecule for further modification in A. brasiliensis.
Furthermore, since atrofuranic acid (13) was identified from both, A. niger and A. brasiliensis,
cross-chemistry on a benzoquinone core seems not limited to A. niger but appears common to
Aspergillus species from section Nigri.
Phylogeny of fungal atromentin synthetases
The identification of AbrA from A. brasiliensis acting as atromentin synthetase under in vitro
conditions tempted us to study the phylogenetic relationship of fungal NRPS-like enzymes.
The failure to produce a functional chimeric protein from the gene fusion of MelA and InvA5,
but successful fusions between MelA and AtrAAt led to the speculation of a separated
phylogeny of atromentin synthetases in ascomycetes and basidiomycetes. Therefore, we
extracted the thioesterase domains of all fungal NRPS-like enzymes characterised so far by
using InterPro (Finn et al., 2017). Sequences were aligned by Clustal Omega (Sievers and
Higgins, 2018) and used to calculate a phylogenetic tree with IQ-Tree (Kalyaanamoorthy et
al., 2017) that was plotted with iTOL (Letunic and Bork, 2016). The thioesterase domain from
the polyketide synthase TerA (Gressler et al., 2015) served as outgroup (Fig. 5). More details
are provided in the STAR methods. Indeed, atromentin synthetases originating from
basidiomycetes (AtrA from Tapinella panuoides, InvA5 from P. involutus and GreA from
Suillus grevillei) formed a cluster that was distinct from all thioesterase domains from
Aspergillus species. While the number of NRPS-like enzymes with known products is limited,
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a tendency for clustering of enzymes producing the same product also became visible among
the Aspergillus-derived enzymes, especially aspulvinone E and atromentin synthetases showed
a close phylogenetic relationship. This supports the idea that this close phylogenetic
relationship enabled the successful generation of functional chimeric proteins. These results
additionally imply that atromentin synthetases from basidio- and ascomycetes evolved
independently. However, to confirm this assumption, additional enzymes from both families
need to be characterised.
Discussion
Although non-reducing NRPS-like enzymes generally only use aromatic α-keto acids as 
substrates, they are responsible for the formation of a large variety of different natural products.
The main interconnecting core structures identified so far are furanones, benzoquinones and
dioxolanones, which arise from the action of the C-terminal thioesterase domain. However,
due to the limited number of non-reducing NRPS-like enzymes characterised so far, prediction
of the thioesterase chemistry by sequence pattern analysis remains difficult. Previous work
suggested a catalytic triad made from serine, asparagine and histidine in combination with a
branched-chain aliphatic amino acid and two proline residues as indicative for benzoquinone
core formation (Braesel et al., 2015). While this may still hold true, more discriminating amino
acids seem to be required for core structure prediction. The aspulvinone E synthetases MelA
and ApvA also resemble this benzoquinone forming amino acid pattern, but contain an
essential cysteine instead of a serine in the catalytic triad. An oxidative environment (Geib et
al., 2016) or the exchange of the cysteine by a serine inactivates the aspulvinone E synthetase
MelA. This indicates that formation of a substrate thioester is essential for the furanone-
forming chemistry of this specific thioesterase. However, other furanone core forming enzymes
with a substitution pattern different to that from aspulvinone E (3), such as the
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microperfuranone (7) synthetase MicA from A. nidulans (Yeh et al., 2012) also contain a serine
rather than a cysteine and, thus, form a substrate oxoester in the active site. Therefore, the
substrate thioester formation in aspulvinone E synthetases proceeds differently and depicts an
exception in furanone core production rather than the rule. This shows that understanding of
the precise chemistry of thioesterase domains from non-reducing NRPS-like enzymes remains
limited and more reliable predictions on the core structure formation will require the analysis
of a protein crystal structure and the characterisation of additional enzymes for identification
of prognostic sequences patterns.
To convert the furanone forming MelA protein into a benzoquinone forming enzyme, domain
swapping currently appears as the method of choice, although a close phylogenetic proximity
may be a prerequisite for the success of such experiments. Previous studies have shown that
the exchange of the thioesterase domain of an A. terreus aspulvinone E synthetases with that
from an A. terreus butyrolactone synthetase successfully converted the enzyme into a
butyrolactone IIa synthetase (van Dijk, Guo and Wang, 2016). Our first approach on MelA
from A. terreus (Geib et al., 2016) in combination with InvA5 from the basidiomycete P.
involutus (Braesel et al., 2015) failed, whereas a combination with the atromentin synthetase
AtrAAt from A. terreus (Hühner et al., 2018) was successful. This clearly demonstrates that a
conversion is possible but may be limited to domain exchanges within species rather than
across fungal divisions. In agreement, our phylogenetic analysis indicates a significant distance
between NRPS-like enzymes from asco- and basidiomycetes (Fig. 5). The identification of an
additional atromentin synthetase from A. brasiliensis will allow further domain exchange
studies to analyse the possibility of successful combinations of NRPS-like enzymes from
aspergilli deriving from different sections.
Interestingly, despite functional expression of atromentin synthetases in both A. niger and A.
oryzae, we were surprised to detect only marginal amounts of atromentin in A. niger. The fact
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that we discovered the yet undescribed metabolite atrofuranic acid (13) as well as the
metabolites gyroporin (11) and p-hydroxybenzoic acid (12) implies that the physiology of A.
niger initiates a cross-specificity and cross-chemistry event on the NRPS-like enzyme.
The host-physiology dependent cross-chemistry described here differs from that described for
the biosynthesis of the meroterpenoids austinol and dehydroaustinol in A. nidulans, in which
one biosynthesis gene cluster contains a polyketide synthase producing an orsellinic acid core
structure, whereas a second biosynthesis gene clusters is responsible for the prenylation of the
polyketide moiety (Lo et al., 2012). In contrast, the production of atrofuranic acid (13) and
other products observed in A. niger is independent from a specific cross-acting biosynthesis
gene cluster as A. niger does not seem to contain its own intrinsic atromentin synthetase. It also
appears unlikely that atromentin (6) acts as a precursor molecule for any of the metabolites in
A. niger as feeding with atromentin (6) did not result in the production of atrofuranic acid (13).
Therefore, atrofuranic acid (13) may not derive from an oxidative ring-opening of atromentin
(6). In contrast, feeding of atrofuranic acid (13) resulted in the production of gyroporin (11)
and metabolite X. Based on the analysis of atrofuranic acid generated from 2-13C-labelled L-
tyrosine in combination with previous labelling studies performed on atromentin (Gill and
Steglich, 1987), we hypothesise the biosynthesis pathway for metabolites produced in A. niger
as proposed in Fig. 6. A re-direction of the chemistry of the thioesterase domain under
physiologic condition in A. niger gives rise to a dihydrofuroic acid, even though it is unclear
whether the proposed reaction occurs with the substrate being tethered to the thioesterase
domain as depicted in Fig. 6. It would also be conceivable that the re-direction of the
thioesterase chemistry promotes the release of a linear intermediate, which is subsequently
converted into a dihydrofuroic acid. In any case, dehydration and oxidation would then lead to
the formation of atrofuranic acid (13). As we did not detect an intermediate without the final
hydroxylation, this modification either occurs prior to the final release from the enzyme or
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occurs instantly and quantitatively after product release. The speculation on a quantitative
hydroxylation in A. niger without detection of an intermediate lacking the hydroxylation is also
in agreement with previous studies on A. terreus terrein biosynthesis. Expression of the terrein
synthase gene terA in A. niger should lead to the production of the polyketide 2,3-dehydro-6-
hydroxymellein. However, the modified terrein precursor 6,7-dihydroxymellein was isolated
from A. niger extracts even without traces of 2,3-dehydro-6-hydroxymellein being detected
(Zaehle et al., 2014).
While p-hydroxybenzoate seems to spontaneously derive from incubation of atrofuranic acid
in the culture broth, the biosynthesis of gyroporin (11) might proceed via metabolite X.
Thereby, the structure of metabolite X could derive from a Piancatelli-type rearrangement
(Piutti and Quartieri, 2013; Verrier et al., 2018), which is subsequently decarboxylated and
oxidised to form gyroporin (11). Interestingly, if this biosynthetic pathway holds true, it differs
from gyroporin (11) production as described for P. involutus during biosynthesis of involutin
(Braesel et al., 2015). In P. involutus, atromentin (6) acts as precursor for gyroporin (11)
biosynthesis, in which an oxidative ring contraction of atromentin (6) first results in the
production of gyrocyanin. Gyrocyanin can then either become converted into involutin or, by
a further oxidation event into gyroporin (6) (Fig. 6). Since atrofuranic acid (13) has not been
detected in P. involutus and, in turn, gyrocyanin was not found in A. niger the biosynthesis of
gyroporin (11) may indeed differ among these organisms. However, the elucidation of the
structure of the unstable metabolite X will be a prerequisite to confirm the biosynthesis route
of gyroporin (11) in A. niger.
Despite the cross-chemistry events observed in A. niger during the expression of atromentin
synthetases, this study confirmed that atromentin synthetases are not limited to basidiomycetes
but seem to be widely distributed also among ascomycetes. Nevertheless, it needs to be
confirmed that atromentin (6) is indeed an intermediate or final metabolite produced in the
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original ascomycete hosts. A recent study showed that the NRPS-like enzyme AtrAAt from A.
terreus produces atromentin (6) when heterologously expressed in yeast (Hühner et al., 2018),
but it needs to be confirmed that atromentin is also produced in A. terreus. Similarly, we
discovered the atromentin synthetase AbrA from A. brasiliensis. When abrA was expressed in
the A. oryzae expression platform, atromentin (6) was produced in significant amounts and no
other by-products were observed. Not unexpectedly, expression in A. niger resulted in the
production of p-hydroxybenzoic acid (12), gyroporin (11) and, mainly, atrofuranic acid (13).
However, most interestingly, when abrA was homologously expressed in A. brasiliensis
atrofuranic acid (13) rather than atromentin (6) was the major metabolite produced. This
suggests that (i) atromentin (6) also undergoes cross-chemistry in A. brasiliensis, indicating
that modifications of benzoquinione core structures are common to Aspergillus species of the
section Nigri and (ii) atromentin (6) is unlikely to be a product that can be identified from A.
brasililiensis. Finally, as A. brasiliensis produces atrofuranic acid (13), it appears unlikely that
the genes forming a putative biosynthesis gene cluster with abrA (Fig. 4G) act on atromentin
(6). Additional analyses will be required to identify the respective metabolite(s) produced in A.
brasiliensis, but the existence of these possibly modifying enzymes also supports the function
of non-reducing NRPS-like enzymes to act as producers of core intermediates in secondary
metabolite biosynthesis. Further examples for such biosynthesis gene clusters are the formation
of Asp-melanin (Geib et al., 2016) and aspulvinone H (9) (Guo et al., 2013) from aspulvinone
E (3), involutin from atromentin (6) (Braesel et al., 2015) or terrequinone A (1) from
didemethylasterriquinone (Schneider et al., 2007; Balibar et al., 2007). Given the fact that
NRPS-like enzymes are widespread in fungal genomes and their metabolites have hardly been
characterised yet, these enzymes and their accompanying biosynthesis gene clusters provide a
treasure chest for metabolites of pharmacological interest. Nevertheless, characterisation of
products from NRPS-like enzymes may be hampered by cross-chemistry occurring on
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metabolite core structures during heterologous expression. Therefore, it is recommended to use
different heterologous expression platforms in parallel to elucidate the true nature of products
formed from uncharacterised NRPS-like enzymes.
Significance
While terpenes, polyketides and products from non-ribosomal peptide synthetases (NRPS) are
known for a great variety of biological activities, products from NRPS-like enzymes are less
well studied. However, metabolites analysed so far show phytotoxic, antiviral, anti-
proliferative and anti-diabetic activities making them interesting candidates for further
exploitation. NRPS-like enzymes with a C-terminal thioesterase (TE) domain catalyse the
condensation of two aromatic α-keto acids by forming connecting indolylquinone, 
benzoquinone, dioxolanone or furanone core structures, but the exact reaction mechanisms are
hardly understood. Current knowledge on sequence patterns in thioesterase domains is too
limited for core structure prediction, as the A. terreus furanone forming aspulvinone E
synthetase MelA was not converted into a quinone forming atromentin synthetase by site-
directed mutagenesis. However, mutagenesis experiments confirmed that MelA forms a
substrate thioester, which is unprecedented in NRPS-like enzymes. Despite the inability of
MelA conversion into an atromentin synthetase by site-directed mutagenesis, this was
successfully achieved by domain swapping. Conversion required use of a thioesterase domain
from an atromentin synthetase of the same species. This successful reassembly from closely
related enzymes may also explain the expansion in the number of NRPS-like enzymes in
individual fungal species. Furthermore, this study demonstrated that host physiology in
heterologous expression has significant impact on product formation. While atromentin
synthetases produce atromentin in vitro and in A. oryzae, cross-chemistry directs the formation
of atrofuranic acid and eventually gyroporin in A. niger. This cross-chemistry was not limited
22
to A. niger, but also occurred in A. brasiliensis, which contains an intrinsic atromentin
synthetase. Therefore, a single enzyme can form different products depending on the
physiology of the producer. While this cross-chemistry widens the product portfolio from
NRPS-like enzymes, a single expression platform might be insufficient when analysing product
formation from yet uncharacterised secondary metabolite biosynthesis genes.
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Figure legends
Figure 1: Metabolites produced by NRPS-like enzymes.
Figure 2: Characterisation and mutation of the aspulvinone E synthetase MelA. A: Partial
sequence alignment from thioesterase domains of four NRPS-like enzymes. InvA5 =
atromentin synthetase from P. involutus, MelA = aspulvinone E synthetase for Asp-melanin
biosynthesis from A. terreus, ApvA = aspulvinone E synthetase for aspulvinone H biosynthesis
from A. terreus, MicA = microperfuranone synthetase from A. nidulans. The catalytic motif
and the proposed fingerprint region directing the core structure formation are highlighted. B:
SDS-PAGE analysis of wild-type and mutated MelA proteins. C: HPLC chromatograms from
in vitro assays from purified MelA proteins shown in (B) in comparison to authentic standards
of aspulvinone E (3), the UV-interconvertible isoaspulvinone E (#) and atromentin (6). The (*)
denotes the peak derived from the substrate 4-hydroxyphenylpyruvate. MI – chimeric
MelA(A):InvA5(T-TE). HPLC runs were recorded at 254 nm.
Figure 3: Analysis of products formed from invA5 expression in A. niger and from
purified InvA5. A and B: Time dependent extraction of (A) culture filtrates and (B) mycelium
from heterologous invA5 expression in the A. niger P2 strain. C: Analysis of metabolite
formation from atrofuranic acid (13). When 13 is incubated for 24 h in sterile culture medium
4-hydroxybenzoic acid (12) is formed. In the presence of A. niger 13 is additionally
transformed into gyroporin (11) and metabolite X. D: InvA5 purification and HPLC analysis
of products formed from an in vitro assay. In A, B and C a modified HPLC method
(COR_ESIA_25-50) was used to achieve higher peak resolution, whereas method COR_ESIA
was used in D. All HPLC runs were recorded at 254 nm. For heterologous expression of
atromentin synthetases in A. niger strains NP4 and ATNT16 and in vitro assay with an invA5
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expressing A. niger cell extract refer to Fig. S1. NMR data for structure elucidation of
compounds are provided in tables S1-S3 and Fig. S2-S3.
Figure 4: Expression of different NRPS-like enzymes in A. niger and A. oryzae and
product analysis by HPLC. A: Background metabolite production in the A. oryzae wild-type
strain RIB40, the expression platform strain A. oryzae OP12 and identification of aspulvinone
E (3) and its cis-isomer isoaspulvinone E (#) from an OP12 strain expressing the melA gene
from A. terreus. B: Analysis of a culture extract of an OP12 strain expressing the atromentin
synthetase invA5. Authentic atromentin (6) was run as a reference standard and confirms the
production of atromentin (6) in A. oryzae. C and D: Analysis of metabolites formed from
recombinant production of the atromentin synthetase AtrAAt and the chimeric proteins
MelA(A):AtrAAt(T-TE) (C1), MelA(A-T):AtrAAt(TE) (C2) and AtrAAt(A-T):MelA(TE) (C2) in A. oryzae
OP12 and A. niger ATNT16. C: Culture extracts from A. oryzae OP12 with accumulation of
atromentin (6). D: Mycelium extractions from A. niger ATNT 16 with accumulation of
atrofuranic acid (13). In C and D the construct AtrAAt(A-T):MelA(TE) (C2) produces aspulvinone
E (3) and isoaspulvinone E (#). E: Cultures and HPLC profiles of extracts from heterologous
expression of abrA from A. brasiliensis in ATNT16 and OP12. F: Homologous overexpression
of abrA in A. brasiliensis and authentic standards of atrofuranic acid (13) and atromentin (6).
For a metabolite screening on A. brasiliensis culture extracts refer to Fig. S5. All HPLC runs
were recorded at 254 nm. G: Putative abrA containing biosynthesis gene cluster in A.
brasiliensis.
Figure 5: Phylogenetic tree of thioesterase domains of NRPS-like enzymes from
basidiomycetes and Aspergillus species. Bootstrap support is shown at the nodes of the tree
and enzyme names and enzymatic activity are provided. The originating organism can be
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extracted from the colour coding. Black letters with grey background denote atromentin
synthetases from the basidiomycetes Tapinella panuoides (AtrA), P. involutus (InvA5) and
Suillus grevillei (GreA). Enzymes in green derive from A. nidulans, in brown from A. terreus
and in red from A. brasiliensis. The thioesterase domain of the polyketide synthase TerA from
A. terreus served as outgroup. For protein accession numbers refer to the STAR methods.
Figure 6: Proposed scheme for metabolite biosynthesis. The predicted biosynthetic pathway
of atrofuranic acid (13) is supported by molecule labelling derived from feeding 2-13C-labelled
L-tyrosine. The three C-atoms from the two tyrosine side-chains are numbered in red and blue
and the 13C-labelled C-atoms are indicated by an additional (*). The purple arrow indicates the
formation of atromentin (6) at the thioesterase domain of atromentin synthetases, which acts as
precursor for gyrocyanin that can be further converted into gyroporin (11) and involutin as
suggested for P. involutus. Orange arrows indicate the formation of atrofuranic acid in
Aspergillus species from section Nigri. A subsequent Piancatelli-type rearrangement and
decarboxylation results in the formation of gyroporin (11). For NMR-data of atrofuranic acid
(13) refer to the supporting Fig. S2-4 and table S2.
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STAR Methods
Contact for reagents and resource sharing
Further information and reasonable requests for resources and reagents should be directed to
and will be fulfilled by the Lead Contact, Matthias Brock (Matthias.brock@nottingham.ac.uk).
Requests for fungal strains and plasmids will need a material transfer agreement (MTA), if a
use is intended.
Experimental model and subject details
The A. niger strain FGSC A1144 (Fungal Genetics Stock Center, Manhattan, Kansas, USA)
served as parental wild-type strain for generation of the expression platform strains A. niger P2
(Gressler et al., 2015) and ATNT16 (Geib and Brock, 2017). A. niger strain N402 (also known
as ATCC 64974; American Type Culture Collection, Manassas, Virginia, USA) was used as
parental strain for generation of the expression platform strain NP4. A. oryzae RIB40 (also
known as ATCC 42149, American Type Culture Collection) served as parental strain for
generating the expression platform strain OP12. In addition, the A. brasiliensis strain CBS
101740 (CBS-KNAW Collection, Utrecht, Netherlands) was used in this study. Genotypes of
individual transformants and media compositions are listed in the key resource table or table
S5. All Aspergillus strains were cultivated at 28 °C. Liquid cultures were agitated on a rotary
shaker at 150 rpm.
Method details
Preparation of conidia suspensions and selection of fungal transformants
Conidia suspensions were prepared from agar slopes of AMM(-N)G50Gln10 solidified with
2% agar. Slopes were overlaid with 4 ml of phosphate buffered saline (PBS) containing 0.01%
Tween 20 and conidia were collected by scrapping cultures with a cotton swab. For inoculation
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of media with a defined amount of conidia, suspensions were filtered through a 40 µm cell
strainer (Greiner bio-one), washed once with PBS/Tween and counted by use of an improved
Neubauer chamber. For selection of A. niger transformants either 140 μg/ml hygromycin B, 40 
μg/ml phleomycin or 0.1 μg/ml pyrithiamine were used. For selection of A. oryzae
transformants either 30 μg/ml phleomycin or 0.1 μg/ml pyrithiamine were added. 
Transformants from A. brasiliensis were selected by media supplementation with 0.1 μg/ml 
pyrithiamine. For transformation of expression platform strains ATNT16pyrGx24 and
OP12_pyrG- with deleted or disrupted pyrG gene the pyrG gene from A. nidulans FGSC A4
was used as a selection marker and protoplasts were regenerated on media without addition of
10 mM uridine.
Generation of expression platform strains A. niger NP4, A. oryzae OP12 and pyrG-
strains
To generate alternative expression platform strains the wild-type strains A. niger N402 and A.
oryzae RIB40 were selected as parental strains. Both strains were transformed with a
PamyB:terR_ptrA plasmid (Gressler et al., 2015) that contains the A. terreus transcriptional
regulator gene terR under control of the A. oryzae amylase promoter PamyB and the ptrA gene
as pyrithiamine resistance marker for selection of transformants. Resulting transformants were
checked by Southern blot analysis for single copy integration of the construct, resulting in the
selection of A. niger NP4 and A. oryzae OP12 as alternative expression platform strains. For
using the pyrG gene from A. nidulans as selectable marker in transformation of the expression
platform strains A. niger ATNT16 and A. oryzae OP12, the intrinsic pyrG genes were either
deleted or disrupted. For generating an OP12 pyrG negative strain 1  108 conidia were plated
on 50 mM HEPES pH 7.0 buffered AMM(-N)G50Gln10 solid medium containing 20 mM
uridine and 2 mg/ml fluoroorotic acid (Melford Biolaboratories). Plates were incubated at 28°C
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for 7 days and three individual colonies were recovered. Subsequent plating on media with or
without 10 mM uridine confirmed uridine auxotrophy of the strains. Genomic DNA was
isolated from one of the strains, the pyrG gene amplified and sequenced. Sequencing results
with P1+P2 (see table S4 for oligonucleotide sequences) confirmed a deletion of 8 bases at
position 583-590bp in the pyrG coding region. The strain was termed OP12_pyrG-. For
ATNT16 a pyrG deletion cassette was generated by amplifying a 1 kb upstream region with
oligonucleotides P3+P4 and a 1 kb downstream region with P5+P6. Oligonucleotides contained
overlapping sequences to the KpnI restriction site of pUC 19 and to the Not1 excised ptrA gene
from plasmid ptrA_pJET1.2. The three fragments were assembled with the KpnI restricted
pUC19 vector by in vitro recombination. The deletion fragment was excised by KpnI restriction
and used for transformation of A. niger ATNT16 using pyrithiamine as selection marker.
Resulting transformants were repeatedly streaked on pyrithiamine containing plates before
tested for uridine auxotrophy. Southern blot analysis confirmed that strain ATNT16pyrGx24
contained a pyrG deletion without ectopic integrations of the deletion construct and was used
as pyrG negative ATNT16 strain in subsequent studies.
Generation of a URA-blaster cassette for transformation of pyrG- expression platform
strains
For transformation of pyrG negative fungal expression platform strains a URA-blaster cassette
was generated. The cassette consisted of a direct repeat of an 800 bp internal E. coli prpB
fragment flanking the entire A. nidulans pyrG gene including its promoter and terminator
region. The direct repeats enable excision of the pyrG gene by mitotic recombination allowing
the marker to be re-used in subsequent transformation approaches. As recipient plasmid for the
URA-blaster cassette the ble-gene was excised by NotI restriction from plasmid pUC-ble (Geib
and Brock, 2017) leaving a NotI restriction site in the resulting pUC_NotI plasmid. The direct
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repeats of the prpB gene with overlaps to the NotI restriction site of pUC_NotI and the A.
nidulans pyrG gene were amplified from plasmid pQE30_prpB (Brock et al., 2001) with
oligonucleotides P7+P8 and P9+P10. A 1900 bp fragment enclosing the A. nidulans pyrG gene
was amplified from genomic DNA of A. nidulans strain FGSC A4 with oligonucleotides
P11+P12. The three PCR fragments were mixed with the NotI-restricted pUC_NotI plasmid
and the URA-blaster cassette was assembled by in vitro recombination using the In-Fusion®
HD Cloning System (Takara/Clonetech). The URA-blaster was excised by NotI restriction and
used to replace alternative resistance markers in SM-Xpress plasmids.
Generation of expression constructs for production of NRPS-like and chimeric proteins
All PCR amplifications for gene cloning procedures were carried out by using the Phusion
Green Hot Start II High-Fidelity DNA Polymerase (ThermoFisher Scientific) in a
SpeedCycler2 (Analytik Jena). PCR for generation of the mutated melACS gene producing the
amino acid exchange C733S was performed with oligonucleotide pair P13+P14 and P15+P16.
Similarly, PCR for generation of the mutated melAND producing the amino acid exchange
N760D was performed with P13+P17 and P18+P19. The chimeric melAA:invA5T-TE construct
was assembled by amplifying the melA part with P13+P20 and the invA5 part with P21+P22.
The complete invA5 gene was amplified with P23+P22. Assembly of the respective amplicons
in SM-Xpress plasmids was performed by in vitro recombination using the In-Fusion® HD
Cloning System (Takara/Clonetech). For full-length expression of the melA gene in A. oryzae
OP12, the previously generated plasmid his_melA-SM-Xpress (Geib et al., 2016) was used for
fungal transformation.
For heterologous expression of the atrAAt gene and gene fusions of melA and atrAAt in A. niger
ATNT16pyrGx24 and A. oryzae OP12pyrG-, PCR was performed on genomic DNA of A.
terreus wild-type strains SBUG844 and A1156. The full-length atrAAt gene was amplified with
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oligonucleotides P24+P25 and cloned by in vitro recombination into the his-SM-Xpress_URA
plasmid. For the gene fusion construct melA(A):atrAAt(T-TE) (C1) the melA sequence was
amplified with oligonucleotides P26+P27 and the atrAAt sequence with P28+P25. For the gene
fusion construct melA(A-T):atrAAt(TE) (C2) the melA sequence was amplified with
oligonucleotides P26+P29 and the atrAAt sequence with P30+P25. Finally, for the gene fusion
construct atrAAt(A-T):melA(TE) (C2) the atrAAt sequence was amplified with oligonucleotides
P24+P40 and the melA sequence with P41+P42.
For heterologous expression of the abrA in A. niger and A. oryzae expression platform strains
the gene was amplified from genomic DNA of A. brasiliensis CBS101740 using
oligonucleotides P31+P32. The resulting PCR fragment was fused by in vitro recombination
with plasmid his_SM-Xpress_hph in which the original phleomycin resistance gene was
replaced by the hygromycin B resistance cassette hph.
For homologous constitutive expression of the A. brasiliensis abrA gene in A. brasiliensis the
gene was placed under control of the gpdA promoter from A. nidulans. The 992 bp promoter
region of the gpdA gene was amplified with P33+P34 from genomic DNA of A. nidulans strain
FGSC A4. The abrA gene was amplified from genomic DNA of A. brasiliensis CBS101740
with P35+P36. Both amplicons were fused by in vitro recombination into the HindIII
(ThermoFisher Scientific) restricted ptrA_pJET1.2 plasmid (Fleck and Brock, 2010).
All assembled plasmids were transferred into and propagated in chemically competent
Escherichia coli DH5α (Mix & Go!, Zymo Research). Plasmids were purified using the 
NucleoSpin Plasmid kit (Macherey and Nagel).
Fungal transformation and transformant analysis
Mycelia for protoplast generation were generated by inoculating YEPD media with 2 - 3  106
conidia/ml of the strain to be transformed. After 22 h mycelium was harvested and incubated
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for 1 h at 28°C without agitation in citrate-phosphate buffer pH 7.3 containing 10 mM
dithiotreitol. Protoplasts were generated in 20 ml potassium phosphate-buffered (pH 5.8)
osmotic medium with 0.6 M potassium chloride as osmotic stabiliser and 1.3 g VinoTaste Pro
(Novozymes) and 0.1g lysing enzyme (Sigma-Aldrich). Protoplasts were washed and mixed
with the respective plasmids and PEG solution (25% PEG8000, 50 mM CaCl2, 10 mM
Tris/HCl pH 7.5) and incubated for 30 min on ice. After transformation protoplasts were
regenerated on AMM(-N)G50Gln10 agar plates containing 1.2 M sorbitol as osmotic stabiliser
and the respective selection marker (Geib and Brock, 2017).
Transformants were streaked twice onto AMM(-N)G50Gln10 agar containing the respective
selectable marker. Genomic DNA from individual transformants was purified using the
MasterPure Yeast DNA kit (Epicenter). Transformants carrying the PamyB:terR construct for
generation of expression platform strains were checked by Southern Blot analysis for single
copy integration. All other transformants carrying specific heterologous gene expression
constructs were checked either by Southern Blot or diagnostic PCR using Phire Green Hot Start
II DNA Polymerase (ThermoFisher Scientific) and oligonucleotides P37+P38 for NRPS-like
enzyme genes and P33+P39 for homologous abrA overexpression.
Southern Blot analysis
Southern Blots were performed by restriction of genomic DNA with suitable restriction
enzymes, separation on a 0.8% agarose gel and transfer of fragments to a positively charged
nylon membrane (Amersham Nylon-Hybond+, GE Healthcare). Gene specific probes were
amplified with Taq DNA Polymerase (NEB) and labelled by incorporation of digoxigenin-11-
dUTP (Roche). Hybridisation was performed over night at 65°C and bands were visualised by
subsequent hybridisation with anti-digoxigenin-alkaline phosphatase Fab fragments (Roche)
and CDPstar (Roche) as substrate.
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Heterologous expression and purification of proteins
All NRPS-like enzymes were cloned with an N-terminal His-tag peptide. Protein purification
followed a protocol as previously described (Geib et al., 2016). In brief, strains were grown in
AMM(-N)Starch2%Gln20Talc for 32 - 40 h at 28 C under constant shaking at 150 rpm.
Mycelium was harvested over Miracloth filter gauze (Merck), rinsed with tap water, pressed
dry between paper tissues and frozen in liquid nitrogen. The mycelium was ground under liquid
nitrogen to a fine powder, suspended in buffer A (50 mM Tris/HCl pH 7.5, 150 mM NaCl and
10% glycerol) and disrupted further by ultrasonication. The cell-free extract and cell debris
were separated by centrifugation at 17 000  g and filtered through a 0.45 μm filter (Sartorius). 
For purification a 3 ml Ni-Sepharose 6 Fast Flow (GE Healthcare) gravity flow column was
used. After application of the cell-free extract, the column was washed with 4 volumes of buffer
A supplemented with 20 mM imidazole and eluted with buffer A supplemented with 200 mM
imidazole. Proteins were desalted by centrifugal concentration (Amicon 15-Ultra, 30 kDa cut-
off, Millipore) and stored in 50% glycerol with 1 mM dithiothreitol at -20°C.
In vitro assays
In vitro product formation from NRPS-like enzymes followed a protocol as previously
described (Geib et al., 2016) with some minor modifications. Purified proteins (0.5 – 1 mg) or
cell-free extract (600 µl; 6 mg total protein) were mixed in a final volume of 5 ml with PIPES
buffer pH 7.5 (100 mM), ATP (10 mM), MgCl2 (15 mM) and 7.5 mM 4-
hydroxyphenylpyruvate. Optionally, 3 mM DTT were added to enzymes containing a cysteine
residue in the active site of the thioesterase domain. Assays were incubated for 18 h at 28°C in
the dark with gentle agitation. For metabolite extraction assays were acidified to pH 3.5 with
HCl and incubated for 10 min on ice. Precipitates were collected by centrifugation. Both, pellet
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and supernatant, were extracted separately with ethyl acetate. The organic solvent was
evaporated under reduced pressure, the residue solved in methanol and analysed by HPLC as
described.
Secondary metabolite analysis
For secondary metabolite analysis liquid cultures of AMM(-N)G50Gln10 (A. niger) or AMM(-
N)Starch2%Gln20 (A. oryzae) were inoculated with 1  106 conidia/ml. For metabolite
extraction from time dependent incubation AMM(-N)G100Gln20 was used. For induction of
heterologous gene expression in A. niger ATNT16 strains the medium was additionally
supplemented with 10 μg/ml doxycycline. After 36 - 48 h or at specifically indicated time 
points, cultures were harvested and separated into a cell-free culture filtrate and mycelium.
Both fractions were extracted with ethyl acetate. The organic solvent layer was collected, dried
over anhydrous sodium sulphate and evaporated under reduced pressure. Residual compounds
were solved in methanol and subjected to HPLC analysis using a Dionex UltiMate3000
(ThermoFisher Scientific) and an Eclipse XDB-C18 column (4.6 × 150 mm, 5 μm; Agilent) 
following a gradient (COR_ESIA) of water + 0.1% formic acid (solvent A) and methanol
(solvent B) with a flow rate of 1 ml/min: 0.5 min 10% B, 15 min 90% B, 17 min 90% B, 17.5
min 100% B, 22 min 100% B, 23 min 10% B, 25 min 10% B. For more detailed resolution of
metabolites obtained from the time dependent extraction of A. niger P2 strains expressing the
invA5 gene a modified gradient (COR_ESIA_25-50) was applied at a flow rate of 1 ml/min:
0.5 min 10% B, 1.5 min 25% B, 12 min 50% B, 14 min 90% B, 15 min 100%B, 18 min 100%
B, 20 min 10% B, 24 min 10% B.
High-resolution electrospray ionisation mass spectrometry (HR-ESI-MS) was carried out on
an Accela UPLC-system combined with an Exactive mass spectrometer (Thermo Scientific).
Separation of individual metabolites was achieved by using a Betasil C18 column (2.1 ×150
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mm, 3 μm; Thermo Scientific) with water + 0.1% formic acid (solvent A) and acetonitrile + 
0.1% formic acid (solvent B) as solvents. The following solvent gradient at a flow rate of 250
μl/min was applied: 1 min 5% B, 16 min 98% B, 19 min 98% B, 20 min 5% B. 
Isolation and structure elucidation of natural products
Metabolites from P2 invA5 or ATNT16 abrA culture filtrates were purified over a Zorbax RX-
C18 column (9.5 × 250 mm, 5 μm) using an Agilent 1200 equipped with an auto-sampler, DAD 
and fraction collector. The following gradient of water + 0.1% TFA (A) and methanol (B) with
a flowrate of 1.8 ml/min was applied: 0.5 min 25% B, 2 min 35% B, 20 min 40% B, 23 min
90% B, 25 min 100% B, 31 min 100% B, 34 min 25% B, 36 min 25% B. Peaks were
automatically collected using slope and threshold parameters.
The 1D and 2D NMR spectra of 11, 12, 13 and 14 were recorded at 300 K on a Bruker Avance
III spectrometer (Bruker BioSpin) at 500 and 600 MHz for proton and at 125 and 150 MHz for
carbon spectra. DMSO-d6 was used as solvent and internal standard. The solvent signals were
referenced to δH 2.49 ppm and δC 39.5 ppm.
For final structure elucidation of atrofuranic acid (13) an acetylation was performed using the
following method: pyridine (14 µl, 173.5 µmol) was added slowly to a suspension of 13 (9.1
mg, 26.8 µmol) in acetic anhydride (821 µl, 90.5 mmol) and stirred on ice for 30 min. The
temperature was then raised to room temperature and stirred for another 18 h. After addition
of 8 ml water, the mixture was transferred to a CHROMABOND® C18ec-column (0.5 g),
washed with 16 ml of water and eluted with 16 ml methanol. After evaporation of the solvent
a complete triacetlyation of 13 was confirmed by HPLC-MS on an Agilent 1260 HPLC system
equipped with a C18 column (Zorbax Eclipse XDB, 150 × 4.6 mm, 5 μm) and coupled to a 6130 
Single Quadrupole mass detector by using the following gradient of CH3CN in H2O + 0.1%
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TFA: initial holding of 30% CH3CN for 1 min, then increasing from 30 to 100% CH3CN in 12
min and terminal holding of 100% CH3CN for 8 minutes.
To obtain 13C-labelled atrofuranic acid (13), two 50 ml AMM(-N)G100Gln20 cultures of A.
niger ATNT16 cultures expressing an atromentin synthetase were supplemented with 2.2 mM
2-13C-labelled L-tyrosine and incubated for 48 h at 28°C. Labelled atrofuranic acid (13) was
extracted with ethyl acetate from A. niger mycelium. Extracts were dried under reduced
pressure, solved in methanol, purified by HPLC as described above and subjected to NMR
analyses.
Phylogenetic tree construction
To analyse the phylogenetic relationship of NRPS-like enzymes the thioesterase domain
sequences were extracted by InterPro (Finn et al., 2017) using the alpha/beta hydrolase fold
(SSF53474) as template. The following NRPS-like protein sequences were used: AtrA from
Tapinella panuoides (accession no.: B7STY1); InvA from P. involutus (accession no.:
A0A0S2E7W7.1); GreA from Suillus grevillei (accession no.: I6NXV7.1); MicA from A.
nidulans (accession no.: Q5B7T4.1); TdiA from A. nidulans (accession no.: ABU51602.1);
BtyA from A. terreus (accession no.: AUO29224.1) AtqA from A. terreus (accession no.:
XP_001210786.1); PgnA from A. terreus (accession no.: XP_001217485.1); ApvA from A.
terreus (accession no.: XP_001211182.1); AtrAAt from A. terreus (accession no.:
MG384315.1); MelA from A. terreus (accession no.: KU530117.1); AbrA from A. brasiliensis
(JGI protein ID Aspbr1 165333). The thioesterase domain of the polyketide synthase TerA
from A. terreus (accession no.: Q0D1N9) was used as outgroup. The extracted protein domains
were aligned using Clustal Omega (Sievers and Higgins, 2018) and assemblies were used for
tree calculations with IQ-Tree by identifying the optimal tree building algorithm resulting in a
model with the highest likelihood (Kalyaanamoorthy et al., 2017). Bootstrap support was
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calculated by the ultrafast bootstrap approximation UFBoot2 implemented in IQ-Tree (Hoang
et al., 2018). The results were plotted by using iTOL (Letunic and Bork, 2016).
Quantification and statistical analysis
Does not apply.
Data and software availability
No datasets or software was generated.
Additional resources
No new website/forum was generated. This study did not include a clinical trial.
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Supplementary item titles
Figure S1 - Related to Figure 3: Time dependent extraction of (A) culture filtrates and (B)
mycelium from heterologous invA5 and abrA expression in the A. niger NP4 strain and abrA
expression in A. niger ATNT16 strain. (C) In vitro assay with cell-free extract of an invA5
expressing A. niger strain and 4-hydroxyphenylpyruvate as substrate. Minor amounts of
atrofuranic acid (13) derive from the cell extract. Atromentin (6) is produced as the dominating
metabolite. (D) In vitro assay with purified AbrA protein resulting in the production of
atromentin (6). HPLC files were recorded with COR_ESIa method at 254 nm.
Figure S2 - Related to Figure 3: 1H NMR spectrum of 13 (A), 13C-labelled 13 (B) and 14
(C) in DMSO-d6. D:1H, 1H COSY NMR spectrum of 13 in DMSO-d6
Figure S3 - Related to Figure 3: 1H decoupled 13C NMR spectrum of 13 (A), 13C-labelled
13 (B) and 14 (C) in DMSO-d6
Figure S4 - Related to Figure 3: 1H, 13C HSQC (red) and HMBC (blue) NMR spectrum of
13 (A), 13C-labelled 13 (B) and 14 (= acetylated 13) (C) in DMSO-d6.
Figure S5 - Related to Figure 4: Culture filtrate extracts of A. brasiliensis in comparison to
authentic atromentin and atrofuranic acid standards
Table S1 - Related to Figure 3: NMR data for 12 in DMSO-d6. COSY correlations are
shown as bold bonds. HMBC correlations are shown as arrows.
Table S2 - Related to Figure 3: NMR data for 13 in DMSO-d6. COSY correlations are
shown as bold bonds. Key HMBC correlations are shown as arrows.
Table S3 - Related to Figure 3: NMR data for 14 in DMSO-d6. Key HMBC correlations are
shown as arrows.
Table S4 - Related to STAR methods: Oligonucleotides used in this study.








REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Fungal Strains
E. coli DH5α Zymo Research Zymo 5α
A. niger A1144 P2 (PamyB:terR_ptrA) (Gressler et al., 2015) N/A
A. niger P2 melA (PterA:melA_ble) (Geib et al., 2016) N/A
A. niger P2 melACS (PterA:melACS _ble) This study N/A
A. niger P2 melAND (PterA:melAND _ble) This study N/A
A. niger P2 melAA:invA5T-TE (PterA:melAA:invA5T-TE_ble) This study N/A
A. niger ATNT16 (TetOn:terR_ble) (Geib and Brock, 2017) N/A
A. niger ATNT16pyrGx24 (TetOn:terR_ble; pyrG::ptrA) This study N/A
A. niger N402 American Type Culture Collection N402
A. niger N402 NP4 (PamyB:terR_ptrA) This study N/A
A. niger NP4 invA5 (PterA:invA5_ble) This study N/A
A. niger P2 invA5 (PterA:invA5_ble) This study N/A
A. oryzae RIB40 American Type Culture Collection RIB40
A. oryzae RIB40 OP12 (PamyB:terR_ptrA) This study N/A
A. oryzae RIB40 OP12_pyrG- (PamyB:terR_ptrA; pyrG-) This study N/A
A. oryzae OP12 melA (PterA:melA_ble) This study N/A
A. oryzae OP12 invA5 (PterA:invA5_ble) This study N/A
A. brasiliensis CBS101740 CBS-KNAW Collection CBS101740
A. niger ATNT16 abrA (PterA:abrA_hph) This study N/A
A. oryzae OP12 pyrG- abrA (PterA:abrA_URA) This study N/A
A. brasiliensis OE abrA (PgpdA:abrA_ptrA) This study N/A
Chemicals, Peptides, and Recombinant Proteins
VinoTaste Pro Novozymes Free sample
Lysing enzyme from Trichoderma harzianum Sigma Aldrich Cat#L1412
DMSO-d6 Deutero Cat#00905-
10ml
4-Hydroxylphenylpyruvic acid Sigma Aldrich Cat#114286
Taq DNA Polymerase New England BioLabs Cat#M0273S
Phusion Green Hot Start II High-Fidelity DNA Polymerase ThermoFisher Scientific Cat#F537S
Phire Green Hot Start II DNA Polymerase ThermoFisher Scientific Cat#F124L
digoxigenin-11-dUTP Sigma Aldrich Cat#1109308
8910
anti-digoxigenin-alkaline phosphatase Fab fragments Sigma Aldrich Cat#1109327
4910
CDPstar Sigma Aldrich Cat#1204167
7001
Soluble Starch Fisher Scientific Cat#DF0178-
17-7
Acetic anhydride puriss. p.a., ACS Reag. Fluka Cat#45830
Pyridin, EMSURE® ACS Reag. Merck Cat#1.09728.
0500
Critical Commercial Assays
In-Fusion® HD Cloning System Takara/Clonetech Cat#639647
MasterPure Yeast DNA kit Epicenter Cat#MPY802
00




PamyB:terR_ptrA_pUC19 (Gressler et al., 2015) N/A
SM-Xpress (Gressler et al., 2015) N/A
his_SM-Xpress (Geib et al., 2016) N/A
his_SM-Xpress_hph This study N/A
PterA:his_melA_ble_SM-Xpress (Geib et al., 2016) N/A
PterA:his_melACS _ble_SM-Xpress This study N/A
PterA:his_melAND _ble_SM-Xpress This study N/A
PterA:his_melAA:invA5T-TE_ble_SM-Xpress This study N/A
PterA:his_invA5_ble_SM-Xpress This study N/A
PterA:abrA_his_SM-Xpress_hph This study N/A
PterA:abrA_his_SM-Xpress_URA blaster This study N/A
pJET1.2/blunt (CloneJET) ThermoFisher Scientific Cat#K1232
ptrA_pJET1.2 (Fleck and Brock, 2010) N/A
ble_pUC19 (Geib and Brock, 2017) N/A
PgpdA:abrA_ptrA_pJET1.2 This study N/A
Software and Algorithms
ChemStation version Rev. B. 04. 03 [16] Agilent N/A
Chromeleon version 7.2 ThermoFisher Scientific N/A













Dionex UltiMate3000 ThermoFisher Scientific N/A
Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) Agilent N/A
Agilent 1200 HPLC with autosampler, DAD and fraction
collector
Agilent N/A
EASYstrainer 40 µm Greiner bio-one Cat#542040
Amersham Nylon-Hybond+ GE Healthcare Cat#RPN303
B
SpeedCycler2 Analytik Jena N/A
Miracloth VWR Cat#475855-
1
Amicon 15-Ultra, 30 kDa cut-off Merck Cat#UFC803
024
CHROMABOND C18ec-column (0.5g) MACHEREY-NAGEL Cat#730014
Bruker Avance III spectrometer 500Mhz Bruker N/A
Bruker Avance III spectrometer 600Mhz Bruker N/A
  
Figure S1 - Related to Figure 3: Time dependent extraction of (A) culture filtrates and (B) 
mycelium from heterologous invA5 and abrA expression in the A. niger NP4 strain and abrA 
expression in A. niger ATNT16 strain. (C) In vitro assay with cell-free extract of an invA5 
expressing A. niger strain and 4-hydroxyphenylpyruvate as substrate. Minor amounts of 
atrofuranic acid (13) derive from the cell extract. Atromentin (6) is produced as the dominating 
metabolite. (D) In vitro assay with purified AbrA protein resulting in the production of 
atromentin (6). HPLC files were recorded with COR_ESIa method at 254 nm.
X 11+
12 















Figure S2 - Related to Figure 3: 1H NMR spectrum of 13 (A), 13C-labelled 13 (B) and 14 (C) in DMSO-d6. D: 



















Figure S4 - Related to Figure 3: 1H, 13C HSQC (red) and HMBC (blue) NMR spectrum of 13 (A), 13C-labelled 13 (B) and 14 (= acetylated 13) (C) 
in DMSO-d6.
Figure S5 - Related to Figure 4: Culture filtrate extracts of A. brasiliensis in comparison to 




Table S1 - Related to Figure 3: NMR data for 12 in DMSO-d6. COSY correlations are 
shown as bold bonds. HMBC correlations are shown as arrows. 
 
Position δC, type δH, M (J in Hz) COSYa HMBCb 
1 167.2, C    
2 121.3, C    
3 131.5, CH 7.77, d (8.7) 4 1, 3, 5 
4 115.1, CH 6.81, d (8.7) 3 2, 4, 5 
5 161.6, C    
a COSY correlations are from proton(s) stated to the indicated proton. b HMBC correlations, 
optimized for 7.7 Hz, are from proton(s) stated to the indicated carbon. 
  
Table S2 - Related to Figure 3: NMR data for 13 in DMSO-d6. COSY correlations are 
shown as bold bonds. Key HMBC correlations are shown as arrows. 
  
Position δC, type δH, M (J in Hz) COSYa HMBCb 
1 166.8, Cc    
2 153.8, C / 139.9, Cd    
3 124.5, C    
4 180.6, C    
5 159.6, C / 135.7, Cd    
6 118.5, C    
7 131.4, CHe 7.35, d (8.6) 8 2, 3, 7, 8, 9 
8 114.6, CHe 6.81, d (8.6) 7 2, 6, 7, 8, 9 
9 157.5, C    
9-OH - 9.67, sc  8, 9 
10 180.6, C    
11 126.7, C    
12 131.9, CHe 8.12, d (8.8) 13 10, 12, 13, 14 
13 115.6, CHe 6.95, d (8.8) 12 5, 11, 12, 13, 14  
14 162.5, C    
14-OH - 10.58, sc  13, 14 
a COSY correlations are from proton(s) stated to the indicated proton. b HMBC correlations, 
optimized for 7.7 Hz, are from proton(s) stated to the indicated carbon. c Chemical shifts were 
deduced from the NMR spectra of the labelled compound. d The different chemical shifts 
correspond to isomers of the compound. e Signal refers to two magnetically equivalent carbons. 
  
Table S3 - Related to Figure 3: NMR data for 14 in DMSO-d6. Key HMBC correlations are 
shown as arrows. 
  
Position δC, type δH, M (J in Hz) HMBCa 
1 n.d.   
2 142.1, C   
3 126.7, C   
4 158.8, C   
5 n.d.   
6 125.0, C   
7 130.8, CHb 7.47, d (8.6) 7, 9 
8 121.6, CHb 7.22, d (8.6) 6, 8, 9 
9 150.7, C   
10 180.2, C   
11 133.4, C   
12 130.9, CHb 8.05, d (8.7) 10, 12, 14 
13 122.3, CHb 7.38, d (8.7) 11, 13, 14 
14 154.3, C   
1’ 167.5, C   
2’ 20.0, CH3 2.10, s 1’ 
1’’ 168.9, C   
2’’ 20.9, CH3 2.31, s 1’’ 
1’’’ 169.1, C   
2’’’ 20.9, CH3 2.29, s 1’’’ 
a HMBC correlations, optimized for 7.7 Hz, are from proton(s) stated to the indicated carbon. 
b Signal refers to two magnetically equivalent carbons. 
 
  
Table S4 - Related to STAR methods: Oligonucleotides used in this study. 
primer# Sequence (5’ – 3’) construct 
1 CAGGCGGAGAAACGTGTGG A. ory pyrG 
2 GAGCACCAAATGGTGGCTAG A. ory pyrG 
3 GTGAATTCGAGCTCGGTACCCCTGCAGCTCTGTCATTGC A. nig ΔpyrG 
4 GTATAATACGCGGCCGCGTGTTGATGGAGGGGTTAATG A. nig ΔpyrG 
5 CGTAATCAAGCGGCCGCGGAGGATCGAAGTTCTGATGG A. nig ΔpyrG 
6 CTAGAGGATCCCCGGGTACCGCTGTCCCCTTTAAAGAGGC A. nig ΔpyrG 
7 CTCGGTACCCGCGGCCGCGCAGATTGTTGGCACCATC URA blaster 
8 CAGGTTGTCGAGCTTCTCTTC URA blaster 
9 GCAGATTGTTGGCACCATC URA blaster 
10 GAGGATCCCCGCGGCCGCCAGGTTGTCGAGCTTCTCTTC URA blaster 
11 GAAGCTCGACAACCTGCATGGTGTCCTCGTCGGC URA blaster 
12 GTGCCAACAATCTGCGGAACCTGACTACTACAATGTTG URA blaster 
13 CATCACAGCACCATGCATCACCATCACCATCACCAACCAAGCCTTATTCCCTC melACS 
14 CAAACGCCAACATCGACCCATAGGAATAGCC melACS 
15 ACGGACCATACGCTCTCGCCGGCTATTCCTATGGG melACS 
16 ATCACTGCTGCCATGGTTACATGCCCCTCTCAGCAAG melACS 
17 GAGGTAGATCGAAAGACCCGAC melAND 
18 GTCGGGTCTTTCGATCTACCTC melAND 
19 TGAAATCACTGCTGCTTACATGCCCCTCTCAGCAAG melAND 
20 GGAGAGCTTACCCAGGGTCG melA:invA5 
21 CTGGGTAAGCTCTCCAGGGCTCGTCTC melA:invA5 
22 ATCACTGCTGCCATGGTTACAGACCACGAGCTTCGAG invA5 
23 CATCACAGCACCATGGGCAGCAGCCATCATCATCATC invA5 
24 CATCACCATCACCATGGATCTTTCAAGAACCTCCAACAGC atrAAt 
25 CTGCTGTTATCCATGGCTAAATTCCCCGTGCTTCCAAC atrAAt 
26 CATCACCATCACCATGGACAACCAAGCCTTATTCCCTC melA 
27 CCGGGAGAGCTTACCCAG melA C1 
28 GGTAAGCTCTCCCGGTCTAGTATCAAGGCAAGCTACG atrA C1 
29 CTCGCGAACCGTGGTGTTTTC melA C2 
30 CACCACGGTTCGCGAGCTCAGCGCCGCGCTGCA atrA C2 
31 CATCACCATCACCATGGATCATTTGCCAATCTTACTGTATTC abrA 
32 AATCACTGCTGTTATCCATGGTCAAATTCCTCTTGCATCTAGTG abrA 
33 GAGGTTTAGAGCAAGCTTCCTTATTCGTTGACCTAGC AnPgpdA 
34 AAATGACATTGTGATGTCTGCTCAAGC AnPgpdA 
35 GACATCACAATGTCATTTGCCAATCTTACTG abrA 
36 CTCAGTTTCCTGAAGCTTCTCTACGGTATGCGAGGAAC abrA 
37 CCTCCAAGAGAGATCCAGAC PterA 
38 GAATTTTACCAGTGGCCTAGG TtrpC 
39 CCTGGATAGAACTCTTCCTGC abrA 
40 TTCGCGGACCGTGGTGTTC atrAAt (A+T) 
41 ACCACGGTCCGCGAACTTGCCGCTGCACTGGAC melA (TE) 
42 CTGCTGTTATCCATGGTTACATGCCCCTCTCAGCAAG melA (TE) 
 
  
Table S5 - Related to STAR methods: Media used in this study. 
Minimal media 
AMM(-N) 0.52 g/l KCl, 0.52 g/l MgSO4  7 H2O, 1.52 g/l KH2PO4; 1 ml/l 
1000 Hutner's trace elements; pH 6.5 
G50Gln10 50 mM glucose and 10 mM glutamine 
G50Gln10S1.2 50 mM glucose, 10 mM glutamine and 1.2 M sorbitol 
G100Gln20 100 mM glucose and 20 mM glutamine 
Starch2%Gln20 2% soluble starch and 20 mM glutamine 
Starch2%Gln20Talc 2% soluble starch and 20 mM glutamine, 10 g/l talc 
CA1% 1% casamino acids 
AMM(-N) 6 g/l NaNO3, 0.52 g/l KCl, 0.52 g/l MgSO4 ´ 7 H2O, 1.52 g/l 
KH2PO4; 1 ml/l 1000 Hutner's trace elements; pH 6.5 
G50  
Complex media 
YEPD 20 g/l peptone, 10 g/l yeast extract, 5 g/l glucose 
YM 3 g/ l yeast extract, 3 g/l malt extract, 5 g/l meat peptone; pH 6.6 
GSTY 30 g/l glucose, 2.5 g/l soytone, 0.5 g/l yeast extract, 1 g/l KH2PO4, 1 
g/l MgSO4  7 H2O, 0.5 g/l NaCl, 0.5 g/l CaCl2  2 H2O, 2 mg /l 
FeCl3  2 H2O, 2 mg/l ZnSO4  7 H2O; pH 5.5 
PB 20 g/l potato broth; pH 6.5 
CYA 3 g/l NaNO3, 5 g/l yeast extract, 30 g/l sucrose, 1.3 g/l K2HPO4 x 3 
H2O, 0.5 g/l MgSO4 x 7 H2O, 0.5 g/l KCl, 10 mg/l FeSO4 x 7 H2O, 5 
mg/l CuSO4 x 5 H2O, 5 mg/l ZnSO4 x 7 H2O; pH 6.5 
Sab 10 g/l peptone, 20 g/l glucose; pH 6.5 
ACM 10 g/l glucose, 1 g/l yeast extract,2 g/l peptone, 1 g/l casamino acids, 
0.075 g/l adenine, 10 ml/l vitamin solution (400 mg/l p-
aminobenzoic acid, 50 mg/l thiamine HCl, 2 mg/l biotin, 100 mg/l 
nicotinic acid, 250 mg/l pyridoxine HCl, 1.4 g/l choline chloride, 
100 mg/l riboflavin), 20 ml/l salt solution (26 g/l KCl, 26 g/l MgSO4 
 7 H2O, 76 g/l KH2PO4), 200 µl/l trace element solution (40 mg/l 
Na2B4O7  10 H2O, 800 mg/l CuSO4  5 H2O, 800 mg/l FePO4  
H2O, 800 mg/l MnSO4  4 H2O, 800 mg/l NaMoO4  2 H2O, 8 g/l 
ZnSO4); pH 6.5 
 
 
 
 
